Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice
Abstract
:1. Introduction
2. Materials and Methods
2.1. Animals
2.2. Drugs and Animal Models
2.3. Behavior Testing
2.3.1. Measurement of Mechanical Allodynia—Von Frey Filament Test
2.3.2. Measurement of Thermal Hyperalgesia—Hot Plate Test
2.4. Immunohistochemistry Staining of Intraepidermal Nerve Fibers
2.5. Histological Evaluation of Sciatic Nerves
2.5.1. Toluidine Blue Staining
2.5.2. Transmission Electron Microscopy
2.6. Real-Time Quantitative Polymerase Chain Reaction (qPCR)
2.7. Mass Spectrometry to Detect GSSSG Administered by Oral Gavage
2.8. In Vitro Studies
2.8.1. Primary DRG Neuron Isolation and Histological Evaluation
2.8.2. Primary Cortical Neuron Isolation and ROS Assay
2.9. Cancer Cell Line and Viability Assay
2.10. Statistical Analysis
3. Results
3.1. GSSSG Prevented Paclitaxel-Induced Mechanical Allodynia
3.2. GSSSG Prevented Loss of Intraepidermal Nerve Fibers Induced by Paclitaxel
3.3. GSSSG Prevented the Paclitaxel-Induced Loss of Unmyelinated Axons in the Sciatic Nerve
3.4. GSSSG Prevented Mitochondrial Swelling in Unmyelinated Sciatic Nerve Axons
3.5. 34S-Labeled GSSSG Was Detected in DRG, Spinal Cord, Brain, and Liver after Oral Administration
3.6. GSSSG Prevented Paclitaxel-Induced Axonal Degeneration and Fragmentation of Mitochondria in Cultured Primary DRG Neurons
3.7. GSSSG Attenuated Paclitaxel-Induced Increase of Superoxide Levels in Primary Cortical Neurons
3.8. GSSSG Upregulated Antioxidant Signaling in DRG
3.9. GSSSG Did Not Affect the Anti-Tumor Effects of Paclitaxel in a Human Breast Cancer Cell Line
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Gene | Sequence | |
---|---|---|
Nrf2 | Forward | 5′-TCCTCAGCAGAACAGGAACAG-3′ |
Reverse | 5′-CCTCCAAAGGATGTCAATCAA-3′ | |
HO1 | Forward | 5′-AAGCCGAGAATGCTGAGTTC-3′ |
Reverse | 5′-GCCGTGTAGATATGGTACAAGGA-3′ | |
NQO1 | Forward | 5′-AGGATGGGAGGTACTCGAATC-3′ |
Reverse | 5′-AGGCGTCCTTCCTTATATGCTA-3′ | |
GCLC | Forward | 5′-GGACAAACCCCAACCATCC-3′ |
Reverse | 5′-GTTGAACTCAGACATCGTTCCTC-3′ | |
18S | Forward | 5′-CGGCTACCACATCCAAGGAA-3′ |
Reverse | 5′-GCTGGAATTACCGCGGCT-3′ |
References
- Wilson, B.E.; Jacob, S.; Yap, M.L.; Ferlay, J.; Bray, F.; Barton, M.B. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: A population-based study. Lancet. Oncol. 2019, 20, 769–780. [Google Scholar] [CrossRef]
- Seretny, M.; Currie, G.L.; Sena, E.S.; Ramnarine, S.; Grant, R.; MacLeod, M.R.; Colvin, L.A.; Fallon, M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 2014, 155, 2461–2470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scripture, C.D.; Figg, W.D.; Sparreboom, A. Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives. Curr. Neuropharmacol. 2006, 4, 165–172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dougherty, P.M.; Cata, J.P.; Cordella, J.V.; Burton, A.; Weng, H.-R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004, 109, 132–142. [Google Scholar] [CrossRef] [PubMed]
- Colvin, L.A. Chemotherapy-induced peripheral neuropathy: Where are we now? Pain 2019, 160, S1–S10. [Google Scholar] [CrossRef]
- Yang, I.H.; Siddique, R.; Hosmane, S.; Thakor, N.; Höke, A. Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration. Exp. Neurol. 2009, 218, 124–128. [Google Scholar] [CrossRef] [Green Version]
- Pease-Raissi, S.E.; Pazyra-Murphy, M.F.; Li, Y.; Wachter, F.; Fukuda, Y.; Fenstermacher, S.J.; Barclay, L.A.; Bird, G.H.; Walensky, L.D.; Segal, R.A. Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration. Neuron 2017, 96, 373–386.e6. [Google Scholar] [CrossRef] [Green Version]
- Chine, V.B.; Au, N.P.B.; Kumar, G.; Ma, C.H.E. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy. Mol. Neurobiol. 2018, 56, 3244–3259. [Google Scholar] [CrossRef]
- Koltzenburg, M. Neural Mechanisms of Cutaneous Nociceptive Pain. Clin. J. Pain 2000, 16, S131–S138. [Google Scholar] [CrossRef]
- Flatters, S.J.; Bennett, G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 2006, 122, 245–257. [Google Scholar] [CrossRef]
- Xiao, W.H.; Zheng, H.; Zheng, F.Y.; Nuydens, R.; Meert, T.F.; Bennett, G.J. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neu-ropathy in the rat. Neuroscience 2011, 199, 461–469. [Google Scholar] [CrossRef]
- McCormick, B.; Lowes, D.A.; Colvin, L.; Torsney, C.; Galley, H.F. MitoVitE, a mitochondria-targeted antioxidant, limits paclitaxel-induced oxidative stress and mito-chondrial damage in vitro, and paclitaxel-induced mechanical hypersensitivity in a rat pain model. Br. J. Anaesth. 2016, 117, 659–666. [Google Scholar] [CrossRef] [Green Version]
- Duggett, N.A.; Griffiths, L.A.; McKenna, O.E.; Santis, V.; Yongsanguanchai, N.; Mokori, E.B.; Flatters, S.J.L. Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neurop-athy. Neuroscience 2016, 333, 13–26. [Google Scholar] [CrossRef] [Green Version]
- Zheng, H.; Xiao, W.H.; Bennett, G.J. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp. Neurol. 2011, 232, 154–161. [Google Scholar] [CrossRef] [Green Version]
- Ida, T.; Sawa, T.; Ihara, H.; Tsuchiya, Y.; Watanabe, Y.; Kumagai, Y.; Suematsu, M.; Motohashi, H.; Fujii, S.; Matsunaga, T. Reactive cysteine persulfides and Spolythiolation regulate oxidative stress and redox signaling. Proc. Natl. Acad. Sci. USA 2014, 111, 7606–7611. [Google Scholar] [CrossRef] [Green Version]
- Benchoam, D.; Semelak, J.A.; Cuevasanta, E.; Mastrogiovanni, M.; Grassano, J.S.; Ferrer-Sueta, G.; Zeida, A.; Trujillo, M.; Möller, M.N.; Estrin, D.A. Acidity and nucleophilic reactivity of glutathione persulfide. J. Biol. Chem. 2020, 295, 15466–15481. [Google Scholar] [CrossRef]
- Wall, P.D. Vigilance in defense of animal welfare. International Association for the Study of Pain. Pain 1993, 54, 239. [Google Scholar] [CrossRef]
- Chen, L.-H.; Yeh, Y.-M.; Chen, Y.-F.; Hsu, Y.-H.; Wang, H.-H.; Lin, P.-C.; Chang, L.-Y.; Lin, C.-C.K.; Chang, M.-S.; Shen, M.-R. Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy. Pain 2020, 161, 1237–1254. [Google Scholar] [CrossRef]
- Gonzalez-Cano, R.; Boivin, B.; Bullock, D.; Cornelissen, L.; Andrews, N.; Costigan, M. Up–Down Reader: An Open Source Program for Efficiently Processing 50% von Frey Thresholds. Front. Pharmacol. 2018, 9, 433. [Google Scholar] [CrossRef] [Green Version]
- Chaplan, S.R.; Bach, F.W.; Pogrel, J.W.; Chung, J.M.; Yaksh, T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 1994, 53, 55–63. [Google Scholar] [CrossRef]
- Bannon, A.W.; Malmberg, A.B. Models of nociception: Hot-plate, tail-flick, and formalin tests in rodents. Curr. Protoc. Neurosci. 2007, 8, 8–9. [Google Scholar] [CrossRef] [PubMed]
- Lauria, G.; Hsieh, S.-T.; Johansson, O.; Kennedy, W.R.; Leger, J.M.; Mellgren, S.I.; Nolano, M.; Merkies, I.S.J.; Polydefkis, M.; Smith, A.G.; et al. European Federation of Neurological Societi es/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe-deration of Neurological Societies and the Peripheral Ne. Eur. J. Neurol. 2010, 17, 903–912, e44-9. [Google Scholar] [CrossRef] [PubMed]
- Ghnenis, A.B.; Czaikowski, R.E.; Zhang, Z.J.; Bushman, J.S. Toluidine Blue Staining of Resin-Embedded Sections for Evaluation of Peripheral Nerve Morphology. J. Vis. Exp. 2018, e58031. [Google Scholar] [CrossRef] [PubMed]
- Sleigh, J.N.; West, S.J.; Schiavo, G. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels. BMC Res. Notes. 2020, 13, 302. [Google Scholar] [CrossRef] [PubMed]
- Hamid, H.A.; Tanaka, A.; Ida, T.; Nishimura, A.; Matsunaga, T.; Fujii, S.; Morita, M.; Sawa, T.; Fukuto, J.M.; Nagy, P.; et al. Polysulfide stabilization by tyrosine and hydroxyphenyl-containing derivatives that is important for a reactive sulfur metabolomics analysis. Redox. Biol. 2019, 21, 101096. [Google Scholar] [CrossRef]
- Zhang, T.; Ono, K.; Tsutsuki, H.; Ihara, H.; Islam, W.; Akaike, T.; Sawa, T. Enhanced Cellular Polysulfides Negatively Regulate TLR4 Signaling and Mitigate Lethal Endotoxin Shock. Cell. Chem. Biol. 2019, 26, 686–698.e4. [Google Scholar] [CrossRef]
- Takata, T.; Jung, M.; Matsunaga, T.; Ida, T.; Morita, M.; Motohashi, H.; Shen, X.; Kevil, C.G.; Fukuto, J.M.; Akaike, T. Methods in sulfide and persulfide research. Nitric. Oxide 2021, 116, 47–64. [Google Scholar] [CrossRef]
- Perner, C.; Sokol, C.L. Protocol for dissection and culture of murine dorsal root ganglia neurons to study neuropeptide release. STAR Protoc. 2021, 2, 100333. [Google Scholar] [CrossRef]
- Marutani, E.; Kosugi, S.; Tokuda, K.; Khatri, A.; Nguyen, R.; Atochin, D.N.; Kida, K.; Van Leyen, K.; Arai, K.; Ichinose, F. A Novel Hydrogen Sulfide-releasing N-Methyl-d-Aspartate Receptor Antagonist Prevents Ischemic Neuronal Death. J. Biol. Chem. 2012, 287, 32124–32135. [Google Scholar] [CrossRef] [Green Version]
- Gadgil, S.; Ergün, M.; Heuvel, S.A.V.D.; Van Der Wal, S.E.; Scheffer, G.J.; Hooijmans, C.R. A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN). PLoS ONE 2019, 14, e0221787. [Google Scholar] [CrossRef] [Green Version]
- Ferreira, T.A.; Blackman, A.V.; Oyrer, J.; Jayabal, S.; Chung, A.J.; Watt, A.J.; Sjöström, P.J.; Van Meyel, D.J. Neuronal morphometry directly from bitmap images. Nat. Methods 2014, 11, 982–984. [Google Scholar] [CrossRef] [Green Version]
- Homma, S.; Ishii, Y.; Morishima, Y.; Yamadori, T.; Matsuno, Y.; Haraguchi, N.; Kikuchi, N.; Satoh, H.; Sakamoto, T.; Hizawa, N.; et al. Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer. Clin. Cancer Res. 2009, 15, 3423–3432. [Google Scholar] [CrossRef] [Green Version]
- Cho, J.-M.; Manandhar, S.; Lee, H.-R.; Park, H.-M.; Kwak, M.-K. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance. Cancer Lett. 2008, 260, 96–108. [Google Scholar] [CrossRef]
- Szabó, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug. Discov. 2007, 6, 917–935. [Google Scholar] [CrossRef]
- Trecarichi, A.; Flatters, S.J.L. Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy. Int. Rev. Neurobiol. 2019, 145, 83–126. [Google Scholar]
- Cirrincione, A.; Pellegrini, A.D.; Dominy, J.R.; Benjamin, M.E.; Utkina-Sosunova, I.; Lotti, F.; Jergova, S.; Sagen, J.; Rieger, S. Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activation. Sci. Rep. 2020, 10, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Akaike, T.; Ida, T.; Wei, F.; Nishida, M.; Kumagai, Y.; Alam, M.M.; Ihara, H.; Sawa, T.; Matsunaga, T.; Kasamatsu, S.; et al. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. Nat. Commun. 2017, 8, 1177. [Google Scholar] [CrossRef] [Green Version]
- de Beus, M.D.; Chung, J.; Colon, W. Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties. Protein. Sci. 2004, 13, 1347–1355. [Google Scholar] [CrossRef]
- Shinkai, Y.; Abiko, Y.; Ida, T.; Miura, T.; Kakehashi, H.; Ishii, I.; Nishida, M.; Sawa, T.; Akaike, T.; Kumagai, Y. Reactive Sulfur Species-Mediated Activation of the Keap1-Nrf2 Pathway by 1,2-Naphthoquinone through Sulfenic Acids Formation under Oxidative Stress. Chem. Res. Toxicol. 2015, 28, 838–847. [Google Scholar] [CrossRef]
- Smith, G.A.; Lin, T.-H.; Sheehan, A.E.; Naters, W.V.D.G.V.; Neukomm, L.J.; Graves, H.K.; Bis-Brewer, D.M.; Züchner, S.; Freeman, M.R. Glutathione S-Transferase Regulates Mitochondrial Populations in Axons through Increased Glutathione Oxidation. Neuron 2019, 103, 52–65.e6. [Google Scholar] [CrossRef] [Green Version]
- Ding, C.; Wu, Y.; Hammarlund, M. Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria. Elife 2022, 11, e73557. [Google Scholar] [CrossRef] [PubMed]
- Baloh, R.H. Mitochondrial Dynamics and Peripheral Neuropathy. Neuroscientist 2007, 14, 12–18. [Google Scholar] [CrossRef] [PubMed]
- Cuadrado, A.; Manda, G.; Hassan, A.; Alcaraz, M.J.; Barbas, C.; Daiber, A.; Ghezzi, P.; León, R.; López, M.G.; Oliva, B.; et al. Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacol. Rev. 2018, 70, 348–383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bessaguet, F.; Danigo, A.; Bouchenaki, H.; Duchesne, M.; Magy, L.; Richard, L.; Sturtz, F.; Desmoulière, A.; Demiot, C. Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia. Pain 2018, 159, 2538–2546. [Google Scholar] [CrossRef] [PubMed]
- Mo, M.; Erdelyi, I.; Szigeti-Buck, K.; Benbow, J.H.; Ehrlich, B.E. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J. 2012, 26, 4696–4709. [Google Scholar] [CrossRef] [Green Version]
- Todd, A.J. Neuronal circuitry for pain processing in the dorsal horn. Nat. Rev. Neurosci. 2010, 11, 823–836. [Google Scholar] [CrossRef] [Green Version]
- Hwang, B.-Y.; Kim, E.-S.; Kim, C.-H.; Kwon, J.-Y.; Kim, H.-K. Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats. Korean J. Anesthesiol. 2012, 62, 66–72. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ezaka, M.; Marutani, E.; Miyazaki, Y.; Kanemaru, E.; Selig, M.K.; Boerboom, S.L.; Ostrom, K.F.; Stemmer-Rachamimov, A.; Bloch, D.B.; Brenner, G.J.; et al. Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice. Antioxidants 2022, 11, 2122. https://doi.org/10.3390/antiox11112122
Ezaka M, Marutani E, Miyazaki Y, Kanemaru E, Selig MK, Boerboom SL, Ostrom KF, Stemmer-Rachamimov A, Bloch DB, Brenner GJ, et al. Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice. Antioxidants. 2022; 11(11):2122. https://doi.org/10.3390/antiox11112122
Chicago/Turabian StyleEzaka, Mariko, Eizo Marutani, Yusuke Miyazaki, Eiki Kanemaru, Martin K. Selig, Sophie L. Boerboom, Katrina F. Ostrom, Anat Stemmer-Rachamimov, Donald B. Bloch, Gary J. Brenner, and et al. 2022. "Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice" Antioxidants 11, no. 11: 2122. https://doi.org/10.3390/antiox11112122